Loading stock data…
$27.89+0.51 (+1.84%)
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States.
Progyny, Inc. in the Healthcare sector is trading at $27.89 with a market capitalization of $2.1B. Wall Street consensus targets $34.42 (12 analysts), implying a +23.4% move over the next 12 months. The stock is currently 16% below its 52-week high of $33.06, remaining 15.0% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $350.51M↑ | $328.50M↑ | $318.40M↑ | $313.35M↓ | $332.87M |
| Gross Profit | $89.30M↑ | $83.07M↑ | $76.88M↑ | $72.83M↓ | $78.97M |
| Operating Income | $40.00M↑ | $35.38M↑ | $15.22M↓ | $21.53M↓ | $24.36M |
| Net Income | $28.05M↑ | $24.23M↑ | $12.48M↓ | $13.86M↓ | $17.11M |
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cyc...